MedPath
NMPA Approval

Selexipag Tablets

国药准字H20249720

December 10, 2024

Drug Information

司来帕格片

片剂

按司来帕格(C₂₆H₃₂N₄O₄S)计 0.4mg

化学药品

December 10, 2024

Company Information

Applicant Company

浙江省杭州市钱塘区白杨街道11号大街10号

Manufacturing Company

浙江省杭州经济技术开发区11号大街10号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

司来帕格片 - NMPA 批准文号 | MedPath